Poster Tour 3: Cannabis, ketamine and psychedelic research
Tracks
.
| Monday, November 9, 2026 |
| 12:30 PM - 1:05 PM |
Speaker
APSAD 2026
Poster Tour 3: Introduction and Welcome
12:30 PM - 12:35 PMBiography
Ms Danielle Dawson
Phd Candidate
The University Of Queensland
Self-reported reasons for medical and nonmedical cannabis use in Australia: findings from the 2023 International Cannabis Policy Study
12:45 PM - 12:50 PMBiography
Danielle is a PhD candidate at the National Centre for Youth Substance Use Research. Her clinical experience in the field of psychology has led to a deep interest in cannabis and public health. Her research investigates the epidemiology of medicinal cannabis in Australia.
Mr Antoni Pazeski
Research Officer
Hunter New England Local Health District, Drug and Alcohol Clinical Services
From Click to Clinic: How recruitment pathways shape demographic composition in a phase III multisite randomised controlled trial: The CBD for CUD study.
12:50 PM - 12:55 PMBiography
Antoni Pazeski is an early career researcher working at Hunter New England Local health district, working on qualitative and quantitative studies in drug and alcohol addiction.
Arshman S Sahid early career researcher working at South East Sydney Local health district working on clinical trials in addiction.
Mr Sam Lasham
Phd Candidate
University Of Auckland
A survey exploration of psilocybin mushroom use in Aotearoa New Zealand
12:55 PM - 1:00 PMBiography
Sam is a PhD candidate at the University of Auckland researching psilocybin mushroom use in Aotearoa through a harm‑reduction lens. He is also national coordinator of Students for Sensible Drug Policy Aotearoa, a Psilver Linings NZ board member, and member of Harm Reduction Coalition Aotearoa and the Global Psychedelics Consortium.
Dr Anjali Bhardwaj
Clinical Trial Lead
University of Sydney/ South Eastern Sydney Local Health District
A Phase II Study of Medicinal Cannabis Products in the Treatment of Chronic Pain in Patients with Opioid Dependence: a Study Protocol
1:00 PM - 1:05 PMBiography
Anjali is a Clinical Trial Lead at the University of Sydney and a research expert at leading clinical trials with Medicinal Cannabis.